Mednax Proclaims Management Appointments

James D. Swift, MD Appointed Chief Working Officer; Curtis B. Pickert, MD Appointed Chief Doctor Government

FORT LAUDERDALE, Fla., Could 18, 2022–(BUSINESS WIRE)–Mednax, Inc. (NYSE: MD) at this time introduced two appointments to additional strengthen its working and scientific management. The Firm named James D. Swift, MD as Chief Working Officer and Curtis B. Pickert, MD as Chief Doctor Government. Each Drs Swift and Pickert have been with the Firm for over a decade and have held increasing management roles over that point.

“Jim and Curt are invaluable doctor leaders who’ve strengthened Pediatrix for a few years,” stated Mark S. Ordan, Chief Government Officer of Mednax. “Their new elevated roles underscore our commitments each to the best high quality affected person care doable and to considerate, strategic operational assist and development.”

dr Swift joined Mednax in 2009 and most not too long ago served because the Firm’s Government Vice President and Chief Growth Officer. Beforehand, he served as Regional President of the South Central Area for Pediatrix. dr Swift acquired his medical diploma from the College of Well being Sciences/The Chicago Medical College and accomplished his residency in inside drugs and pediatrics at Loma Linda College Medical Heart and his fellowship in pediatric vital care at Harbor-UCLA Medical Heart and Youngsters’s Hospital of Orange County .

dr Pickert joined Mednax in 2009 and most not too long ago served because the Firm’s Government Vice President, Medical Providers Division. Beforehand, he served as President of the Medical Providers Division, Chief Medical Officer of the Western Division, and Vice President, South Central Area for the Firm’s Pediatrix Division. dr Pickert earned his medical diploma and accomplished his residency in pediatrics on the College of Kansas (Kansas Metropolis and Wichita). He’s board-certified in pediatrics and pediatric vital care drugs.


Mednax, Inc. is a nationwide medical group comprised of the nation’s main suppliers of training doctor companies beneath the Pediatrix® model. Pediatrix-affiliated clinicians are dedicated to offering coordinated, compassionate and clinically wonderful companies to ladies, infants and youngsters throughout the continuum of care, each in hospital settings and office-based practices. Specialties embody obstetrics, maternal-fetal drugs and neonatology complemented by 18 pediatric subspecialties, in addition to a newly expanded space of ​​major and pressing care clinics. The group’s high-quality, evidence-based care is bolstered by investments in analysis, training, quality-improvement and security initiatives. The corporate was based in 1979 as a single affiliated neonatology apply and at this time supplies its extremely targeted and infrequently vital care companies by means of greater than 4,700 affiliated physicians and different clinicians in 38 states and Puerto Rico. To study extra about Pediatrix, go to or comply with us on Fb, Instagram, LinkedIn, Twitter and the Pediatrix weblog. Mednax funding data might be discovered at

Sure statements and knowledge on this press launch could also be deemed to comprise forward-looking statements throughout the that means of the Non-public Securities Litigation Reform Act of 1995, Part 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Part 21E of the Securities Alternate Act of 1934, as amended. Ahead-looking statements might embody, however aren’t restricted to, statements regarding the Firm’s aims, plans and methods, and all statements, apart from statements of historic details, that deal with actions, occasions or developments that we intend, count on, venture, imagine or anticipate will or might happen sooner or later. These statements are sometimes characterised by terminology akin to “imagine,” “hope,” “might,” “anticipate,” “ought to,” “intend,” “plan,” “will,” “count on,” “estimate,” ” venture,” “positioned,” “technique” and related expressions, and are based mostly on assumptions and assessments made by the Firm’s administration in gentle of their expertise and their notion of historic traits, present circumstances, anticipated future developments and different elements they imagine to be applicable. Any forward-looking statements on this press launch are made as of the date hereof, and the Firm undertakes no responsibility to replace or revise any such statements, whether or not because of new data, future occasions or in any other case. Ahead-looking statements aren’t ensures of future efficiency and are topic to dangers and uncertainties. Necessary elements that might trigger precise outcomes, developments, and enterprise choices to vary materially from forward-looking statements are described within the Firm’s most up-to-date Annual Report on Kind 10-Ok and its Quarterly Reviews on Kind 10-Q, together with the sections entitled ” Danger Elements”, as nicely the Firm’s present studies on Kind 8-Ok, filed with the Securities and Alternate Fee, and embody the influence of the COVID-19 pandemic on the Firm and its monetary situation and outcomes of operations; the results of financial circumstances on the corporate’s enterprise; the results of the Inexpensive Care Act and potential modifications thereto or a repeal thereof; the Firm’s relationships with government-sponsored or funded healthcare applications, together with Medicare and Medicaid, and with managed care organizations and business medical health insurance payors; the influence of shock billing laws; the Firm’s skill to adjust to the phrases of its debt financing preparations; the corporate’s transition to a third-party income cycle administration supplier; the influence of the divestiture of the Firm’s anesthesiology and radiology medical teams; the influence of administration transitions; the timing and contribution of future acquisitions; the results of share repurchases; and the results of the corporate’s transformation initiatives, together with its reorientation on, and development technique for, its pediatrics and obstetrics enterprise.

View supply model on


Charles Lynch
Senior Vice President, Finance and Technique
954-384-0175 ext. 5692
[email protected]

Leave a Comment